Concord Biotech has announced the early retirement of its Chief Financial Officer (CFO), Lalit Sethi, effective close of business hours on January 5, 2026. Mr. Sethi cited personal reasons for his decision. The company has initiated the process to ensure a smooth transition. The trading window for the company’s securities will remain closed for 48 hours following this announcement.
CFO Retirement Announcement
Lalit Sethi, Chief Financial Officer (CFO) of Concord Biotech, has announced his intention to retire early due to personal reasons. His retirement will be effective from the close of business hours on January 5, 2026. Mr. Sethi submitted his formal notice on December 8, 2025.
Smooth Transition Planned
Concord Biotech acknowledged Mr. Sethi’s contribution and has stated its commitment to ensuring a seamless transition. An early retirement letter was also enclosed with the announcement.
Trading Window Closure
The trading window for dealing in the company’s securities was closed on December 8, 2025 and will remain closed for 48 hours following this announcement. This measure is in place to prevent any potential insider trading activities.
Source: BSE
